Skip to main content
. 2017 Nov 20;8(63):106527–106537. doi: 10.18632/oncotarget.22507

Figure 6. Graphic overview of the inhibitory effect played by EZH2 and MALAT1 on miR-29b expression.

Figure 6

The cartoon shows that MALAT1 and EZH2 negatively regulates miR-29b expression by increasing H3K27me3 of miR-29a/b-1 promoter, thus affecting levels of miR-29b oncogenic targets SP1, MCL-1 and CDK6.